Freshfields advised Roivant in sale of Dermavant to Organon. Organon & Co. has announced the acquisition of Dermavant Sciences Ltd., a subsidiary of Roivant Sciences Ltd.,...
You must be a Standard 1 Year member to access this content.
Freshfields advised Novartis on its exclusive license agreement with Arvinas for a potential first-in-class prostate cancer treatment. Novartis, a global healthcare company, has entered into an...
You must be a Standard 1 Year member to access this content.
Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...
You must be a Standard 1 Year member to access this content.
